Skip to main content
. 2020 Sep 11;2(6):632–640. doi: 10.1016/j.cjco.2020.09.004

Figure 4.

Figure 4

Clinical presentations of MIS-C. MIS-C patients typically present with shock with or without ventricular dysfunction, Kawasaki-like disease, or fever with inflammation. There are a variety of treatment options, with practice variability. COVID-19, coronavirus disease 2019; IVIG, intravenous immunoglobulin; MIS-C, multisystem inflammatory syndrome in children; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.